Complex chronic diseases have a common origin


By loading the video, you agree to YouTube's privacy policy.
Learn more

Load video

Focusing exclusively on genomics, proteomics, and microbiomics leaves a critical gap in our understanding of complex chronic diseases. Despite painstaking efforts, scientists and clinicians often struggle to predict disease trajectory and identify early markers, leading to costly studies that yield disappointing results. Metabolomics can close the gap and revolutionize complex chronic disease research.

While genomics and proteomics provide essential data, metabolomics sheds light on the interplay between genetics, microbiome, and environmental factors such as nutrition. These insights improve our understanding of complex chronic disease progression and early diagnostics, two areas that are pivotal to achieving the level of precision medicine needed for effective interventions. Without metabolomics, these invaluable discoveries will remain out of reach.

In this whitepaper discover how to:

  • Gain a holistic understanding of complex chronic diseases through metabolism
  • Increase the power of your study by combining other omics with metabolomics to reveal associations
    out of reach for other omics alone
  • Focus on what matters in your subjects’ phenotype and obtain detailed descriptions of disease metabolism
    providing substantial advantage
  • Learn about metabolites and pathways driving progression to complex chronic diseases
  • Uncover the metabolites that will enable earlier disease detection
  • Build better cohorts with improved participant selection by exploiting knowledge of metabolism to
    maximize study impact and significance

Enter your details below ↓